These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26510278)

  • 1. Delayed scrutiny: Reported problems with birth control device expose gaps in FDA post-market surveillance.
    Rice S
    Mod Healthc; 2015 Jul; 45(30):16-8. PubMed ID: 26510278
    [No Abstract]   [Full Text] [Related]  

  • 2. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 3. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA and the medical device approval process.
    Guez G; Garg A
    Dent Implantol Update; 2012 May; 23(5):33-7. PubMed ID: 22594003
    [No Abstract]   [Full Text] [Related]  

  • 5. Recalls. FDA, industry cooperate to protect consumers.
    Nordenberg T
    FDA Consum; 1995 Oct; 29(8):24-7. PubMed ID: 10151838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First step taken in FDA-issued unique device identification system.
    Hanoon M
    OR Manager; 2015 Mar; 31(3):16-7. PubMed ID: 25842716
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical Device Recalls in Radiation Oncology: Analysis of US Food and Drug Administration Data, 2002-2015.
    Connor MJ; Tringale K; Moiseenko V; Marshall DC; Moore K; Cervino L; Atwood T; Brown D; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):438-446. PubMed ID: 28463163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
    Janetos TM; Ghobadi CW; Xu S; Walter JR
    Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of FDA medical device recall in 2005-2006].
    Zhang Q; Liu S; Yan Y; Fang P
    Zhongguo Yi Liao Qi Xie Za Zhi; 2011 Jul; 35(4):280-3. PubMed ID: 22097754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical device vigilance at FDA.
    Gross TP; Kessler LG
    Stud Health Technol Inform; 1996; 28():17-24. PubMed ID: 10164091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Software-related recalls: an analysis of records.
    Simone LK
    Biomed Instrum Technol; 2013; 47(6):514-22. PubMed ID: 24328977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What you should know about device recalls.
    OR Manager; 2002 Apr; 18(4):21. PubMed ID: 11962164
    [No Abstract]   [Full Text] [Related]  

  • 14. Device user regulations, not user friendly.
    Cooney J
    AOHA; 1991 Jun; 35(6):4. PubMed ID: 10116065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply chain: hospital recall management criticized.
    Lee J
    Mod Healthc; 2014 Nov; 44(47):12. PubMed ID: 25591317
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA is gold standard of review.
    Leahey MB
    BMJ; 2010 Dec; 341():c7004. PubMed ID: 21139000
    [No Abstract]   [Full Text] [Related]  

  • 17. Users to report device-related deaths to FDA.
    OR Manager; 1991 Jan; 7(1):1, 13. PubMed ID: 10110321
    [No Abstract]   [Full Text] [Related]  

  • 18. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
    Nordberg M
    Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
    [No Abstract]   [Full Text] [Related]  

  • 19. Total recall. Providers are taking the lead in revamping system for handling questionable drugs and medical devices.
    Lee J
    Mod Healthc; 2011 Aug; 41(32):28, 30. PubMed ID: 21879697
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.